Missed our in-booth sessions at HIMSS22? Went to the session, but want to learn more?
Check out our follow-up webinar series.
For this webinar, Lirio’s Chief Artificial Intelligence Scientist, Chris Symons, Ph.D., takes you through how Machine Learning (ML) has the potential to drive a behaviorally-responsive intelligence platform that understands your patients beyond standard propensity modeling or predictive analytics.
You can expect to learn:
No matter what your patients’ reasons are for not getting vaccinated, reaching them with the right message at the right time will require a tailored communication approach. Discover best practices for overcoming barriers to vaccine adoption with personalized communication.
Managing diabetes and the related co-morbidities requires consistent physician care to monitor key factors like A1C and ensure proper medications are available to the patient. One of the largest health systems in the US partnered with Lirio to co-develop a Precision Nudging™ solution utilizing hyper-personalized patient communications for people with diabetes.
Breast cancer is the most diagnosed form of cancer among women in the United States, impacting nearly 1 in every 8 women. This year alone over 280,000 women will be diagnosed with invasive breast cancer. In response to this and other scientifically identified barriers, a top 20 health system partnered with Lirio to create a Precision Nudging™ solution to deliver hyper-personalized messages specifically designed to move patients to schedule and attend their mammograms.